港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

诺诚健华

成交量：- -

成交额：- -

市值：- -

市盈率：- -

高：- -

开：- -

低：- -

收：- -

数据加载中...

总览公司新闻公告

公司资料

公司名字：

诺诚健华

交易所：

SEHK

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

https://cn.innocarepharma.com

邮编：

- -

电话：

- -

传真：

- -

简介：

诺诚健华医药有限公司是一家主要从事生物医药业务的投资控股公司。公司发现、研发及商业化潜在同类最佳及首创的用于治疗癌症及自身免疫性疾病的药物。公司建立了具有内部研发能力的一体化生物医药平台，包括药物靶目标识别和验证、临床前评估、临床试验设计和执行、药物制造和质量控制，以及商业化生产及销售。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/90009/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"90009","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"90009\",,,,,undefined,":{"symbol":"90009","market":"HK","secType":"STK","nameCN":"诺诚健华","latestPrice":0,"timestamp":1748592000000,"preClose":0,"halted":9,"volume":0,"delay":0,"floatShares":25034000,"shares":225290000,"eps":0,"marketStatus":"休市中","change":0,"latestTime":"05-30 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1748827800000},"marketStatusCode":7,"adr":0,"listingDate":1584892800000,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1748568600000,1748577600000],[1748581200000,1748592000000]],"volumeRatio":0,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688428","market":"SH","secType":"STK","nameCN":"诺诚健华","latestPrice":24.02,"timestamp":1748588400000,"preClose":22.99,"halted":0,"volume":7613700,"delay":0,"premium":"-100.00"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"90009\",,,,,undefined,":{"symbol":"90009","floatShares":25034000,"roa":"--","roe":"--","lyrEps":0,"shares":225290000,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"https://cn.innocarepharma.com","compareEarnings":[{"period":"1week","weight":-0.0132},{"period":"1month","weight":0.0529},{"period":"3month","weight":0.0152},{"period":"6month","weight":0.199},{"period":"1year","weight":0.2775},{"period":"ytd","weight":0.161}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"诺诚健华医药有限公司是一家主要从事生物医药业务的投资控股公司。公司发现、研发及商业化潜在同类最佳及首创的用于治疗癌症及自身免疫性疾病的药物。公司建立了具有内部研发能力的一体化生物医药平台，包括药物靶目标识别和验证、临床前评估、临床试验设计和执行、药物制造和质量控制，以及商业化生产及销售。","exchange":"SEHK","name":"诺诚健华","nameEN":"InnoCare Pharma"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"90009\",market:\"HK\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/90009\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"90009\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"90009\",market:\"HK\",delay:false,,,undefined,":{}}}